Connect with us

Breaking News

Rubio Bill will Upend Biden Admin’s “Equity” Approach to Antibody Treatments for Covid-19



Rubio Bill will Upend Biden Admin's Equity Approach to Antibody Treatments for Covid-19-ss-Featured

Sen. Marco Rubio (R-Fla.) has proposed a bill that intends to upend the Biden administration’s approach of using “equity” in the distribution of monoclonal antibody treatments for the coronavirus.

On Tuesday, the Florida senator introduced the Treatment Restoration for Emergency Antibody Therapeutics (TREAT) Act as a response to a change done by the current administration that forces states to go through the HHS to get treatments. The changes made by the Biden administration also placed a limit on the number of treatments each state can get.

Before this, medical providers had the ability to directly order antibody treatments from the supplier.

If the proposal passes, it would stop HHS from enforcing policies that would stop health care providers and hospitals from buying monoclonal antibody treatments directly from distributors or manufacturers.

“This abrupt change in policy from the Biden administration is nothing but an attempt to punish Florida,” Rubio mentioned in a statement sent via email to Fox News. He added, “We cannot let vindictive, politically motivated actions by this administration jeopardize the health and safety of Floridians and others.”

“My bill would bring back fairness by allowing hospitals and other appropriate health care facilities to directly access this life-saving treatment from manufacturers,” Rubio went on to say.

Republican Sens. Marsha Blackburn, Rick Scott, Kevin Cramer, and Roger Marshall all join Rubio as co-sponsors.

Up Next:

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Copyright © 2022 Breaking News Alerts. This copyrighted material may not be republished without express permission. The information presented here is for general educational purposes only. MATERIAL CONNECTION DISCLOSURE: You should assume that this website has an affiliate relationship and/or another material connection to the persons or businesses mentioned in or linked to from this page and may receive commissions from purchases you make on subsequent web sites. You should not rely solely on information contained in this email to evaluate the product or service being endorsed. Always exercise due diligence before purchasing any product or service. This website contains advertisements.